Stocks to sell

Plenty of traders are still willing to risk their hard-earned capital on electric vehicle (EV) manufacturer Lucid Group (NASDAQ:LCID). I wish I could offer them some comfort and a positive outlook. However, LCID stock investors need to prepare for a crash landing. Lucid Group’s recently released results only add to the bearish thesis, unfortunately. Lucid Group’s
EV stocks have been the subject of investment-related conversation for years. With Tesla (NASDAQ:TSLA) constantly commanding headlines over the past five years, you’d have to live under a rock to have missed the growing EV trend. The push toward net zero is intensifying, and most agree that electric cars will be part of that transition. Governments worldwide
Among cannabis stocks, SNDL (NASDAQ:SNDL) has been one that screens well as a value play. Even though this Canada-based integrated cannabis company isn’t cheap on a price-to-earnings basis, SNDL stock has for quite some time traded at a discount to its tangible book value. But investors who have bought it based on its low valuation
It’s fine to seek out low-priced tech stocks, but I definitely do not recommend Exela Technologies (NASDAQ:XELA) stock. Exela Technologies has financial problems and the company’s shares are at risk of being delisted from the Nasdaq exchange. So, there’s too much risk to justify an investment in Exela Technologies. Headquartered in Texas, Exela Technologies specializes in business
The investor exodus out of Bed Bath & Beyond (NASDAQ:BBBY) has accelerated in recent weeks. Over the past month alone, BBBY stock has tumbled to the tune of 75.2%. This rapid move lower may be piquing the interest of bottom-fishers. After all, couldn’t an ounce of improvement with the distressed home goods retailer’s prospects pave the way
Mullen Automotive (NASDAQ:MULN) stock is once again making headlines, but these latest developments aren’t being met with much excitement based on recent price action. In the past few weeks, this early-stage electric vehicle manufacturer has hit a major milestone. The company has closed on a large financing deal. Shares have barely budged on this news.
So, it’s settled: Canadian cannabis producer Tilray (NASDAQ:TLRY) plans to acquire rival Hexo (NASDAQ:HEXO). It’s debatable, however, whether this is actually a good idea. In the same press release, Tilray disclosed its financial results for the third quarter of fiscal 2023. Suffice it to say, the data doesn’t look promising, and it’s not a good